Scilex Holding Co (SCLX)
NASDAQHealth CareDrug Manufacturers - GeneralSnapshot 2026-11-04
$1.83-1.08%
Close 2026-11-04 · 1-day change
NASDAQHealth CareDrug Manufacturers - GeneralSnapshot 2026-11-04
QuarterlyIQ Insights · SCLX
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -82.8% |
| Our one-year growth estimate | diamond | -19.8% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 63.0 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Elevated risk of a next-quarter earnings miss: this name has been missing across recent quarters and is on a run of consecutive earnings misses. A fundamental tilt, not a price call.
Model as of 2026-11-04 · Compared with 11 industry peers
SCLX — credit agreement
Dated 2026-08-12
Entry into a Material Definitive Agreement. On August 8, 2026 (the “Effective Date”), Scilex Holding Company (the “Company”) entered into a Promissory Note (Revolving Line of Credit) (the “Note”) with Vivasor, Inc. (“Vivasor”), as borrower, pursuant to which the Company established in favor of Vivasor an uncommitted revolving line of credit in a maximum aggregate principal amount of up to $20,000,000 (the “Maximum Credit Amount”). The Note has a stated maturity of 120 months from the Effectiv…
Why it matters: The sale would exchange ACEA Pharma for Phoenix shares. Its status and final terms matter to Scilex's assets.
Watch forScilex confirms the transfer closed and says how many shares ACEA received.
Also watch forScilex reports the deal ended, or that closing conditions remain unmet.
Why it matters: The deal could fund Scilex's growth plans. It still needs final contracts and approvals.
Supportive ifScilex files or announces a closing of the $100 million share sale at $15 per share.
Worry ifScilex says the deal has ended, or reports no closing after required approvals fail.
Why it matters: Scilex has kept losing money, while recent revenue has varied. Better results could ease concern about its need for new capital.
Watch forThe November 13 report shows higher revenue than the prior quarter and a smaller net loss.
Also watch forThe November 13 report shows lower revenue than the prior quarter and a larger net loss.
Why it matters: The company has named repurchases as a capital plan, but reported no recent buyback shares. A clear report would show progress.
Supportive ifA filing reports shares bought back and gives the number of shares or dollars spent.
Worry ifThe next report shows no shares repurchased and gives no amount spent under the agreements.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$258 on $10,000 · ±2.6% | How much price usually moves either way. |
| Bad day | $1,074 loss on $10,000 · 10.7% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $8,694 loss on $10,000 · 86.9% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.